SPC
HUM icon

Slate Path Capital’s Humana HUM Stock Holding History

Slate Path Capital’s Portfolio HUM Stock Details HUM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$429M Buy
1,079,930
+620,230
+135% +$177M 5.94% 4
2026
Q1 		$79.7M Sell
459,700
-493,300
-52% -$101M 1.18% 26
2025
Q4 		$244M Buy
+953,000
New +$250M 3.29% 10

Other funds holding HUM

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $32.7B AUM 17.15% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Slate Path Capital's HUM Position: Q2 2026 in Review

Slate Path Capital increased its Humana (HUM) stake by 135% in Q2 2026, buying an estimated $177M and bringing the position to 1,079,930 shares worth $429M. The position accounts for 5.94% of the portfolio, ranked #4.

Slate Path Capital first reported a position in HUM in Q4 2025 and has held it in 3 quarters since. 922 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Slate Path Capital held 1,079,930 shares of Humana worth $429M as of Q2 2026.
  • Slate Path Capital bought 620,230 Humana shares in Q2 2026, an estimated $177M.
  • Humana made up 5.94% of Slate Path Capital's portfolio in Q2 2026, its #4 holding.
  • Slate Path Capital first reported a position in Humana in Q4 2025 and has held it in 3 quarters since.
  • 922 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Slate Path Capital's 13F filing for Q2 2026, filed 14 Aug 2026.